May 22, 2023
3:2
For every 2 shares held, investors received 3. The price per share adjusted from $14.33 to $9.55.
The split itself did not change the total investment value.
Guangdong Hybribio Biotech Co Ltd Class A (SZSE:300639) operates in the Medical specialties industry.
Guangdong Hybribio Biotech Co Ltd Class A company overviewGuangdong Hybribio Biotech Co Ltd Class A's most recent stock split was on May 22, 2023. It was a 3-for-2 forward split, so shareholders received 3 shares for every 2 they held.
Guangdong Hybribio Biotech Co Ltd Class A (SZSE:300639) has split its stock 5 times: a 2-for-1 split on May 9, 2018, a 6-for-5 split on April 30, 2019, a 443-for-354 split on May 28, 2021, a 3-for-2 split on April 29, 2022, and a 3-for-2 split on May 22, 2023.
Guangdong Hybribio Biotech Co Ltd Class A has split its stock 5 times. This history records 5 forward splits between May 9, 2018 and May 22, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Guangdong Hybribio Biotech Co Ltd Class A's 3-for-2 split on May 22, 2023, every 2 shares became 3 shares.
Guangdong Hybribio Biotech Co Ltd Class A has not announced a new split in our records. Its most recent split was on May 22, 2023, 3 years ago. Companies announce splits in advance, and any new SZSE:300639 split will appear on this page.
Already premium?